Skip to main content
Equibles

LALPATHLAB · Dr. Lal Path Labs Ltd. · Documents

Use LALPATHLAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LALPATHLAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,991.75 INR -17.25 (-0.86%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 11.86K Avg daily vol (3M) 17.37K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 4, 2026
2026
Nov 4
Earnings call
Q2 revenue rises 19.6% as PAT grows 27.5%

Dr. Lal Path Labs Ltd reported Q2 FY27 revenue of Rs. 874 crore, up 19.6%, and PAT of Rs. 194 crore, up 27.5%, with a 22.2% margin. Management expects FY27 revenue growth in the high teens and full-year EBITDA margin slightly above 27.2%.

5 source passages
Revenue for Q2 FY27 came in at Rs. 874 crore compared to Rs. 731 crore in the same quarter last year, reflecting a growth of 19.6%. PAT for Q2 FY27 came in at Rs. 194 crore compared to Rs. 152 crore in the same quarter last year, registering a growth of 27.5% with a PAT margin of 22.2%. I think last year, full year, our EBITDA was 27.2%. I think this year, we should be slightly better than that. Full year. We are looking at maybe FY27 numbers in high-teen growth. Open the document at this passage
Showing 1–3 of 3 documents